160 related articles for article (PubMed ID: 33445465)
1. Homologous Recombination Repair Mechanisms in Serous Endometrial Cancer.
Jönsson JM; Bååth M; Björnheden I; Sahin ID; Måsbäck A; Hedenfalk I
Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33445465
[TBL] [Abstract][Full Text] [Related]
2. Genomic Determinants of Homologous Recombination Deficiency across Human Cancers.
Qing T; Wang X; Jun T; Ding L; Pusztai L; Huang KL
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572800
[TBL] [Abstract][Full Text] [Related]
3. Endometrial Cancers in
Smith ES; Da Cruz Paula A; Cadoo KA; Abu-Rustum NR; Pei X; Brown DN; Ferrando L; Sebastiao APM; Riaz N; Robson ME; Soslow RA; Reis-Filho JS; Mandelker D; Weigelt B
JCO Precis Oncol; 2019; 3():. PubMed ID: 32914019
[TBL] [Abstract][Full Text] [Related]
4. Frequent Homologous Recombination Deficiency in High-grade Endometrial Carcinomas.
de Jonge MM; Auguste A; van Wijk LM; Schouten PC; Meijers M; Ter Haar NT; Smit VTHBM; Nout RA; Glaire MA; Church DN; Vrieling H; Job B; Boursin Y; de Kroon CD; Rouleau E; Leary A; Vreeswijk MPG; Bosse T
Clin Cancer Res; 2019 Feb; 25(3):1087-1097. PubMed ID: 30413523
[TBL] [Abstract][Full Text] [Related]
5. Homologous Recombination Abnormalities Associated With
Albitar M; Zhang H; Pecora A; Waintraub S; Graham D; Hellmann M; McNamara D; Charifa A; De Dios I; Ma W; Goy A
Breast Cancer (Auckl); 2023; 17():11782234231198979. PubMed ID: 37789896
[TBL] [Abstract][Full Text] [Related]
6. Targeted and Shallow Whole-Genome Sequencing Identifies Therapeutic Opportunities in p53abn Endometrial Cancers.
Jamieson A; Sobral de Barros J; Cochrane DR; Douglas JM; Shankar S; Lynch BJ; Leung S; Martin S; Senz J; Lum A; Drew Y; Gilks CB; Huntsman DG; McAlpine JN
Clin Cancer Res; 2024 Jun; 30(11):2461-2474. PubMed ID: 38536067
[TBL] [Abstract][Full Text] [Related]
7. RediScore: Prospective validation of a pipeline for homologous recombination deficiency analysis.
Tsantikidi A; Papazisis K; Floros T; Gazouli M; Papadopoulou E; Tsaousis G; Nasioulas G; Mester A; Milan KP; Gozman B; Afrasanie V; Stanculeanu DL; Trifanescu O; Pescaru F; Militaru C; Papadimitriou C
Oncol Lett; 2023 Nov; 26(5):480. PubMed ID: 37809048
[TBL] [Abstract][Full Text] [Related]
8. Development of a Genomic Signatures-Based Predictor of Initial Platinum-Resistance in Advanced High-Grade Serous Ovarian Cancer Patients.
Li Y; Zhang X; Gao Y; Shang C; Yu B; Wang T; Su J; Huang C; Wu Y; Guo H; Ha C
Front Oncol; 2020; 10():625866. PubMed ID: 33747898
[TBL] [Abstract][Full Text] [Related]
9. Homologous recombination deficiency (HRD) testing in ovarian cancer clinical practice: a review of the literature.
Frey MK; Pothuri B
Gynecol Oncol Res Pract; 2017; 4():4. PubMed ID: 28250960
[TBL] [Abstract][Full Text] [Related]
10. Optical Genome Mapping: Integrating Structural Variations for Precise Homologous Recombination Deficiency Score Calculation.
Sahajpal NS; Mondal AK; Vashisht A; Singh H; Pang AWC; Saul D; Nivin O; Hilton B; DuPont BR; Kota V; Savage NM; Hastie AR; Chaubey A; Kolhe R
Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761823
[TBL] [Abstract][Full Text] [Related]
11. A Benchmark of In-House Homologous Recombination Repair Deficiency Testing Solutions for High-Grade Serous Ovarian Cancer Diagnosis.
Guarischi-Sousa R; Kroll JE; Bonaldi A; Pierry PM; Villela D; Souza CA; Silva JS; Bürger MC; Oliveira FA; de Paula MG; Meliso FM; de Almeida LG; Monfredini PM; de Oliveira AG; Milanezi F; Scapulatempo-Neto C; Yamamoto GL
Diagnostics (Basel); 2023 Oct; 13(21):. PubMed ID: 37958189
[TBL] [Abstract][Full Text] [Related]
12. The RECAP Test Rapidly and Reliably Identifies Homologous Recombination-Deficient Ovarian Carcinomas.
van Wijk LM; Vermeulen S; Meijers M; van Diest MF; Ter Haar NT; de Jonge MM; Solleveld-Westerink N; van Wezel T; van Gent DC; Kroep JR; Bosse T; Gaarenstroom KN; Vrieling H; Vreeswijk MPG
Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 33003546
[TBL] [Abstract][Full Text] [Related]
13.
Huang Y; Ren S; Ding L; Jiang Y; Luo J; Huang J; Yin X; Zhao J; Fu S; Liao J
Precis Clin Med; 2024 Jun; 7(2):pbae009. PubMed ID: 38745917
[TBL] [Abstract][Full Text] [Related]
14. Homologous recombination deficiency should be tested for in patients with advanced stage high-grade serous ovarian cancer aged 70 years and over.
Pitiyarachchi O; Ansell PJ; Coleman RL; Dinh MH; Holman L; Leath CA; Werner T; DiSilvestro P; Morgan M; Tew W; Lee C; Cunningham M; Newton M; Edraki B; Lim P; Barlin J; Spirtos NM; Tewari KS; Edelson M; Reid T; Carlson J; Friedlander M
Gynecol Oncol; 2024 May; 187():221-226. PubMed ID: 38821039
[TBL] [Abstract][Full Text] [Related]
15. Direct prediction of Homologous Recombination Deficiency from routine histology in ten different tumor types with attention-based Multiple Instance Learning: a development and validation study.
Loeffler CML; El Nahhas OSM; Muti HS; Seibel T; Cifci D; van Treeck M; Gustav M; Carrero ZI; Gaisa NT; Lehmann KV; Leary A; Selenica P; Reis-Filho JS; Bruechle NO; Kather JN
medRxiv; 2023 Mar; ():. PubMed ID: 36945540
[TBL] [Abstract][Full Text] [Related]
16. A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signatures.
Diossy M; Sztupinszki Z; Borcsok J; Krzystanek M; Tisza V; Spisak S; Rusz O; Timar J; Csabai I; Fillinger J; Moldvay J; Pedersen AG; Szuts D; Szallasi Z
NPJ Precis Oncol; 2021 Jun; 5(1):55. PubMed ID: 34145376
[TBL] [Abstract][Full Text] [Related]
17. Screening and Testing for Homologous Recombination Repair Deficiency (HRD) in Breast Cancer: an Overview of the Current Global Landscape.
Daly GR; Naidoo S; Alabdulrahman M; McGrath J; Dowling GP; AlRawashdeh MM; Hill ADK; Varešlija D; Young L
Curr Oncol Rep; 2024 Jun; ():. PubMed ID: 38822929
[TBL] [Abstract][Full Text] [Related]
18. Detection and therapeutic implications of homologous recombination repair deficiency in pancreatic cancer: a narrative review.
Tan H; Hosein PJ
J Gastrointest Oncol; 2023 Oct; 14(5):2249-2259. PubMed ID: 37969835
[TBL] [Abstract][Full Text] [Related]
19. Determinants of Homologous Recombination Deficiency in Pancreatic Cancer.
Wattenberg MM; Reiss KA
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572943
[TBL] [Abstract][Full Text] [Related]
20. Exploiting the Prevalence of Homologous Recombination Deficiencies in High-Grade Serous Ovarian Cancer.
Bouberhan S; Philp L; Hill S; Al-Alem LF; Rueda B
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32403357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
